Sonoma Pharmaceuticals, Inc. (SNOA) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2026 | $12.11M | +37.3% |
| 2025 | $8.82M | — |
| 2019 | $10.09M | +7.9% |
| 2018 | $9.35M | +30.6% |
| 2017 | $7.16M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2026 | $12.11M | +37.3% |
| 2025 | $8.82M | — |
| 2019 | $10.09M | +7.9% |
| 2018 | $9.35M | +30.6% |
| 2017 | $7.16M | — |